Compare Two Stocks
Valuation, growth, earnings reaction and guidance credibility, side by sideUNHUnitedHealth Group
FinDog View：Neutral
ZBHZimmer Biomet
FinDog View：Neutral
| Metric | UNH | ZBH |
|---|
| Close | 375.26 | 96.78 |
| Market Cap | $337B | $18.4B |
| 1M | −5.15% | −1.45% |
| P/E (TTM) | 23.9 | 22.1 |
| Forward P/E | 19.7 | 10.8 |
| P/E 5-Yr Percentile | 53 | 25 |
| P/S | 0.8 | 2.1 |
| P/B | 3.2 | 1.4 |
| Dividend Yield | 1.37% | 1.04% |
| Latest Quarter Revenue | $112B | $2.2B |
| Revenue YoY | +0.4% | +4.8% |
| Gross Margin | 88.1% | 70.8% |
| Latest Quarter EPS | 6.04 | 1.03 |
| Avg Post-Earnings Move | ±3.1% | ±2.1% |
| EPS Beat Rate | — | — |
| Guidance Hit Rate | — | — |
| Shareholder Yield | 2.89% | 5.11% |
| 90-Day Net Insider Buying | −$0.66M | −$0.82M |
UNH · Revenue, Last 8 Quarters ($B)
ZBH · Revenue, Last 8 Quarters ($B)
